Mode
Text Size
Log in / Sign up

GPA with cranial involvement often presents as hypertrophic pachymeningitis and can mimic lung cancer metastasisGranulomatosis with polyangiitis can mimic lung cancer in the brain

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider GPA in cranial lesions mimicking leptomeningeal metastasis; use ANCA testing and biopsy.

This publication combines a single case report with a literature review of 33 cases of granulomatosis with polyangiitis (GPA) involving cranial manifestations. The authors describe the clinical features and ANCA serology of these cases and highlight the diagnostic challenge when GPA presents with cranial disease that can resemble leptomeningeal metastasis of lung cancer.

In the literature review, hypertrophic pachymeningitis was the most common cranial manifestation, reported in 51.5% of cases. Serum ANCA was positive in 29 of 33 cases (87.9%). Among ANCA-positive cases, c-ANCA/PR3-ANCA positivity was reported in 23 of 29 (79.3%), corresponding to 69.7% of the total 33 cases. The authors also report that 90.9% of cases improved or stabilized with immunosuppressive or immunomodulatory therapy.

The publication has important limitations. The literature review is based on a small sample of 33 cases, and the case report describes a single instance of misdiagnosis. Adverse events, follow-up duration, and funding or conflicts of interest are not reported. The evidence is descriptive and cannot establish causality or comparative effectiveness.

For practice, the authors stress that GPA can mimic leptomeningeal metastasis of lung cancer. Serum ANCA testing and pathological biopsy are key to differential diagnosis. Clinicians should consider GPA in the differential for cranial lesions, particularly when leptomeningeal metastasis is suspected, and should not rely on imaging alone.

How this fits prior evidence

This review extends prior coverage of lung cancer diagnostics and complications by highlighting a diagnostic pitfall: GPA with cranial involvement can mimic leptomeningeal metastasis of lung cancer. Unlike prior items on prognostic markers (low CALLY index) or imaging segmentation (HSV-Net), this review focuses on clinical differentiation using serum ANCA testing and biopsy. It also adds to the theme of treatment-related and immune-mediated complications previously covered, such as checkpoint inhibitor-associated inflammatory arthritis, by describing a separate immune-mediated condition that can involve the central nervous system.

When a patient has inflammation in the brain, doctors must act fast to figure out why. Sometimes, a rare inflammatory condition called granulomatosis with polyangiitis (GPA) can look almost identical to cancer that has spread from the lungs. This similarity makes it very hard for doctors to tell the difference without specific tests.

Research involving 33 cases shows that many patients with this condition have a specific brain involvement called hypertrophic pachymeningitis. In these cases, the most common finding was a positive result on an ANCA test, which looks for specific antibodies in the blood. These tests help doctors confirm the inflammatory disease rather than cancer.

While the study looked at a small number of cases, it highlights a critical point for doctors. Because the two conditions look so similar, using blood tests and tissue samples is key to getting the right diagnosis. Most patients with this condition saw their symptoms improve or stabilize when treated with medications like glucocorticoids.

What this means for you:
GPA can look like lung cancer in the brain, making specific blood tests and biopsies vital for correct diagnosis.

Common questions

How can doctors tell the difference between GPA and lung cancer?

Because both conditions can look the same in the brain, doctors use serum ANCA testing and pathological biopsies to tell them apart. In a review of 33 cases, 29 out of 33 patients tested positive for ANCA. These specific tests help confirm the inflammatory condition instead of cancer.

What are the common symptoms of GPA in the brain?

The most common finding in the brain for this condition is hypertrophic pachymeningitis, which occurred in 51.5% of the cases reviewed. This is a specific type of inflammation that can mimic the appearance of cancer spread from the lungs.

Does treatment work for this condition?

Yes, the data shows that 90.9% of patients saw their condition improve or stabilize when they received immunosuppressive or immunomodulatory therapy, such as glucocorticoids. You should speak with a doctor to discuss specific treatment plans.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
BackgroundGranulomatosis with polyangiitis (GPA) is an anti-neutrophil cytoplasmic antibody (ANCA)-associated small-vessel vasculitis classically presenting with upper and lower respiratory tract and renal involvement. Central nervous system (CNS) involvement in GPA is rare and is highly prone to being misdiagnosed as intracranial tumor metastasis or intracranial infection.Case reportWe report a 60-year-old female who presented with recurrent headache and conjunctival injection. She had undergone two surgical procedures for “glaucoma” at an outside hospital without headache relief. Upon admission to our hospital, chest CT revealed multiple bilateral pulmonary nodules, highly suspicious for lung cancer; brain MRI showed dural thickening with subdural effusion; lumbar puncture revealed an intracranial pressure (ICP) of 270 mmH₂O, with negative CSF cultures and no tumor cells. The initial diagnosis was leptomeningeal metastasis from lung cancer. However, percutaneous lung biopsy showed no evidence of tumor or infection, and serology revealed positive c-ANCA/PR3-ANCA, leading to a final diagnosis of GPA with clinicoradiologically supported GPA-related pachymeningitis. After glucocorticoid therapy, the patient's headache and other symptoms resolved rapidly.Literature reviewWe reviewed 33 published cases of GPA with cranial involvement and summarized their clinical features. Hypertrophic pachymeningitis (HP) was the most common cranial manifestation (51.5%). Serum ANCA positivity was 87.9% (29/33). Among all 33 cases, c-ANCA/PR3-ANCA was reported in 23 (69.7%); among the 29 ANCA-positive cases, c-ANCA/PR3-ANCA accounted for 79.3% (23/29). After immunosuppressive or immunomodulatory therapy, approximately 90.9% of patients improved or stabilized. These features may serve as clues that should prompt clinicians to consider GPA in the differential diagnosis of pulmonary nodules with pachymeningeal disease and raised intracranial pressure, rather than as established discriminators from lung cancer brain metastasis.ConclusionGPA can present with multiple pulmonary masses, headache, and pachymeningitis, closely mimicking leptomeningeal metastasis of lung cancer. When imaging and clinical presentation are atypical, serum ANCA testing and pathological biopsy are key to differential diagnosis. Clinicians should be alert to this “mimic of malignancy” to avoid unnecessary surgery or radiotherapy.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.